Navigation Links
Novelos Therapeutics and MUSC Present Two Posters at AACR 2007,Annual Meeting

NEWTON, Mass.--(BUSINESS WIRE)--Apr 16, 2007 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the company, in collaboration with Dr. Kenneth Tew and Dr. Danyelle Townsend of the Medical University of South Carolina (MUSC), is making two poster presentations at the ongoing American Association for Cancer Research annual meeting. These presentations will highlight in vivo and in vitro findings with NOV-002, which is currently in a pivotal Phase 3 trial for non-small cell lung cancer and Phase 2 trials for other oncology indications. The posters are available at www.novelos.com 'Our Products', 'NOV-002' section.

"As clinical development of NOV-002 progresses, we continue to add to our understanding of its molecular and cellular mechanisms of action as they may relate to therapeutic activity," said Christopher Pazoles, Ph.D., Vice President of Research & Development of Novelos. "Our ongoing and broad-ranging research collaboration with Drs. Tew and Townsend at MUSC is an important part of that effort."

About Novelos Therapeutics, Inc.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. NOV-002, the lead compound currently in Phase 3 development for lung cancer under a SPA and Fast Track, acts together with chemotherapy as a chemoprotectant and an immunomodulator. NOV-002 is also in Phase 2 development for chemotherapy-resistant ovarian cancer and early-stage breast cancer, and is in addition being developed for acute radiation injury. NOV-205 acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-205 is in Phase 1b development for chronic hepatitis C non-responders. Both compounds have completed clinical trials in humans and have been approved
'"/>




Page: 1 2

Related medicine technology :

1. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:3/26/2015)... , 26. März 2015  Die ... wird vom 1. April 2015 an Zulassungsanträge für ... abgebenden Apotheken annehmen. Seit dem Start des ... Verband über 275 .pharmacy-Domainnamen zugelassen, die für ... Zeiten beantragt wurden. Die NABP startete .pharmacy ...
(Date:3/26/2015)... Mass. , March 26, 2015 /PRNewswire/ ... announced that it will present preclinical and ... at the 2015 American Association for Cancer ... 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The presentations ... engineering and nanoliposomal technology platforms, as well ...
(Date:3/26/2015)... -- Gelesis , a clinical stage biotechnology ... to induce weight loss and improve glycemic control, ... of shares of convertible preferred stock for gross ... of approximately $4 million of outstanding convertible promissory ... to support the continued clinical development of its ...
Breaking Medicine Technology:Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
... NEW YORK, March 29, 2011 Reportlinker.com announces that ... catalogue: Point of Care Diagnostic Testing ... Point of care testing (POCT) enables rapid ... at the point of care facility where results can ...
... Questcor Pharmaceuticals, Inc. (Nasdaq:  QCOR) announced today that executive management ... April 5-6, 2011 at the New York Palace Hotel in ... Officer, is scheduled to present an overview of the Company ... To listen to the audio web cast of the ...
Cached Medicine Technology:Reportlinker Adds Point of Care Diagnostic Testing World Markets 2Reportlinker Adds Point of Care Diagnostic Testing World Markets 3Reportlinker Adds Point of Care Diagnostic Testing World Markets 4Reportlinker Adds Point of Care Diagnostic Testing World Markets 5Reportlinker Adds Point of Care Diagnostic Testing World Markets 6Reportlinker Adds Point of Care Diagnostic Testing World Markets 7Reportlinker Adds Point of Care Diagnostic Testing World Markets 8Reportlinker Adds Point of Care Diagnostic Testing World Markets 9Reportlinker Adds Point of Care Diagnostic Testing World Markets 10Reportlinker Adds Point of Care Diagnostic Testing World Markets 11Reportlinker Adds Point of Care Diagnostic Testing World Markets 12Reportlinker Adds Point of Care Diagnostic Testing World Markets 13Reportlinker Adds Point of Care Diagnostic Testing World Markets 14Reportlinker Adds Point of Care Diagnostic Testing World Markets 15Reportlinker Adds Point of Care Diagnostic Testing World Markets 16Reportlinker Adds Point of Care Diagnostic Testing World Markets 17Reportlinker Adds Point of Care Diagnostic Testing World Markets 18Reportlinker Adds Point of Care Diagnostic Testing World Markets 19
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... MALVERN, PA (PRWEB) March 26, 2015 ... leading providers of continuing medical education, the ... for Culinary Medicine at Tulane University are ... in Culinary Medicine. The interdisciplinary program ... Specialist (CCMS) credential, is designed for physicians, nurse ...
(Date:3/26/2015)... U.S. medical real estate sales transactions ... to an exclusive new report now available only ... (HRE) data firm also announced that it has ... Partners: Harrison Street Real Estate Capital and Zeustra ... going strong, yields compressed, prices per square foot ...
(Date:3/26/2015)... 2015 BioPlus Specialty Pharmacy ... specialty pharmacies, announces the promotion of Sharon Ferrer ... of Pharmaceutical Relations. In this position, Ferrer will ... pharmaceuticals partners and providing key leadership in building ... expansion. , “Over the past seven years ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... begun work into improving the lives of thousands of Cystic ... US-Ireland Research and Development Partnership grant. , The grant ... in the USA with funding for the Queen,s component provided ... Public Health Agency), Northern Ireland and the Medical Research Council. ...
... , THURSDAY, Feb. 3 (HealthDay News) -- A special ... disorder (ADHD) in young children, a new study suggests. ... 8 were placed on a diet containing no processed ... percent of them. And, when suspected trouble foods were ...
... bone marrow to become embryonic-like stem cells, a team ... the onset of the blood cancer leukemia in the ... blood cells obtained from a patient with leukemia," says ... directed a study aimed at generating all-purpose stem cells ...
... -- A single dose of the H1N1 swine flu vaccine ... study found. In order to assess the effectiveness of ... -- Canadian researchers looked at 552 patients with flu-like illness ... Dec. 5, 2009. Pandemic H1N1 was detected in 209 ...
... News) -- If you tend to overindulge in food and ... things you can do to ease the ill effects you ... Dr. Cynthia Yoshida offers the following suggestions: Stay ... Caffeine-free, non-carbonated drinks, such as water, can help lessen the ...
... (HealthDay News) -- The average starting salary for a female ... a huge increase from the $3,600 gap in 1999, finds ... difference isn,t known because it isn,t explained by gender differences ... researchers said. The study authors analyzed survey data from ...
Cached Medicine News:Health News:$2.8 million grant boosts cystic fibrosis research at Queen's 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News:New induced stem cells may unmask cancer at earliest stage 2Health News:Gender Gap in Starting Doctor Pay Grows 2
... STAT analyzer and data management ... to meet the traditional needs of data ... functions for the management of STAT analyzer ... and simple connectivity solution for both STAT ...
... syngo Dynamics network is a ... archiving system using evidence-based reporting ... clinical procedures. It has made ... reality for hospital echocardiography and ...
... dTC is a versatile solution designed to ... from preparation to diagnosis and therapy, ... AXIOM Artis dTC, your cath lab becomes ... that leaves you free to concentrate on ...
... cardiovascular system PLUS ... high-performance transesophageal cardiovascular imaging system ... phased array echocardiography system that ... images, even on your most ...
Medicine Products: